QA: Arcus Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001724521_2023_Arcus_Biosciences_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001724521, Arcus Biosciences Inc.

  xvar xval
0 AssetsCurrent 1,067,000,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 35,000,000
3 remainder_Assets 243,000,000
4 LiabilitiesCurrent 193,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 104,000,000
9 ResearchAndDevelopmentExpense 288,000,000
10 remainder_Expenses 1,000,000
11 remainder_Revenues 112,000,000
12 remainder_NetIncome 14,000,000
13 remainder_ComprehensiveNetIncome -6,000,000
  yvar yval
0 Assets 1,345,000,000
1 Liabilities 193,000,000
2 Expenses 393,000,000
3 Revenues 112,000,000
4 StockholdersEquity 1,152,000,000
5 NetIncome -267,000,000
6 ComprehensiveNetIncome -270,000,000
7 BaseVar 1,031,500,000
8 EconomicCapitalRatio 2.23

Edgar->Model Mapping

Feature Distribution

Change over Time